Skip to main content
×
×
Home

CURRENT ENVIRONMENT FOR INTRODUCING HEALTH TECHNOLOGY ASSESSMENT IN GREECE

  • Chara Kani (a1), Vasilios Kourafalos (a2) and Panagiota Litsa (a2)
Abstract

Objectives: The aim of this study was to describe the current regulatory environment in Greece to evaluate the potential introduction of health technology assessment (HTA) for medicinal products for human use.

Methods: Data sources consist of national legislation on pricing and reimbursement of health technologies to identify the potential need of establishing HTA and its relevant structure.

Results: The pricing procedure regarding medicinal products for human use is based on an external reference pricing mechanism which considers the average of the three lowest Euorpean Union prices. Currently, a formal HTA procedure has not been applied in Greece, and the only prerequisite used for the reimbursement of medicinal products for human use is their inclusion in the Positive Reimbursement List. To restrict pharmaceutical expenditure, a variety of measures—such as clawback mechanisms, rebates, monthly budget caps per physician, generics penetration targeting—have been imposed, aiming mainly to regulate the price level rather than control the introduction of medicinal products for human use in the Greek pharmaceutical market.

Conclusions: Greece has the opportunity to rapidly build capacity, implement, and take advantage of the application of HTA mechanisms by clearly defining the goals, scope, systems, context, stakeholders, and methods that will be involved in the local HTA processes, taking into account the country's established e-prescription system and the recently adapted legislative framework.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      CURRENT ENVIRONMENT FOR INTRODUCING HEALTH TECHNOLOGY ASSESSMENT IN GREECE
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      CURRENT ENVIRONMENT FOR INTRODUCING HEALTH TECHNOLOGY ASSESSMENT IN GREECE
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      CURRENT ENVIRONMENT FOR INTRODUCING HEALTH TECHNOLOGY ASSESSMENT IN GREECE
      Available formats
      ×
Copyright
References
Hide All
1. Polyzos, N, Karakolias, S, Dikeos, C, et al. The introduction of Greek Central Health Fund: Has the reform met its goal in the sector of Primary Health Care or is there a new model needed? BMC Health Serv Res. 2014;14:583.
2. Hellenic Statistical Authority. Greece in figures (October - December 2016) [Internet]. 2016. http://www.statistics.gr/documents/20181/1515741/GreeceInFigures_2016Q4_EN.pdf/b6478000-34ca-4ac5-b6e8-a02ed096ba97 (accessed March 5, 2017).
3. Ministerial Decree C5/17229. Revision of the List of medicinal products for severe diseases of paragraph 2 article 12 of Law 3816/2010. Official Gazette 1119 B; 2016 p. 14291-14302.
4. Law 3816/2010. Article 12. Reintroduction of the Positive Reimbursement List and framework rationalization for medicinal products administered to severe diseases. Official Gazette 6A; 2010 p. 23-29.
5. Kolasa, K, Kalo, Z, Zah, V, Dolezal, T. Role of health technology assessment in the process of implementation of the EU Transparency Directive: Relevant experience from Central Eastern European countries. Expert Rev Pharmacoecon Outcomes Res. 2012;12:283-287.
6. Lopert, R, Ruiz, F, Chalkidou, K. Applying rapid “de-facto” HTA in resource-limited settings: Experience from Romania. Health Policy (New York). 2013;112:202-208.
7. Drummond, MF, Schwartz, JS, Jönsson, B, et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24:244-258.
8. Kaló, Z, Gheorghe, A, Huic, M, Csanádi, M, Kristensen, FB. HTA Implementation roadmap in central and eastern European countries. Health Econ. 2016;25 (Suppl 1):179-192.
9. Gulácsi, L, Rotar, AM, Niewada, M, et al. Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria. Eur J Heal Econ. 2014;(Suppl 1):S13-S25.
10. Zavras, D, Zavras, AI, Kyriopoulos, I-I, et al. Economic crisis, austerity and unmet healthcare needs: The case of Greece. BMC Health Serv Res. 2016;16:309.
11. Vandoros, S, Hessel, P, Leone, T, Avendano, M. Have health trends worsened in Greece as a result of the financial crisis? A quasi-experimental approach. Eur J Public Health. 2013;23:727-731.
12. Vandoros, S, Stargardt, T. Reforms in the Greek pharmaceutical market during the financial crisis. Health Policy. 2013;109:1-6.
13. Fuchs, S, Olberg, B, Panteli, D, Busse, R. Health technology assessment of medical devices in europe: Processes, practices, and methods. Int J Technol Assess Health Care. 2016;27:1-10.
14. Ministerial Decree C5/28408. Pricing Provisions. Official Gazette 1102; 2016 p. 14113-14124.
15. 4336/2015 L. Article 2.5.2.Healthcare. Provisions regarding pensions - Ratification of the Draft Agreement on the Financial Assistance by the European Stability Mechanism (E.S.M) regarding the implementation of the Financing Agreement. Official Gazzette 94A’; 2015 p. 929-1036.
16. Ministerial Decree 70519. Paragraph 3-Rebate provisions. Official Gazette 2243 B’; 2014 p. 27991-28066.
17. Ministerial Decree 62494. Setting prescribing limits for medicinal produtcs. Official Gazette 1920 B’; 2014 p. 24211-24218.
18. Law 4316/2014. Urgent arrangments for the implementation of agreement on fiscal goals and srtuctural reforms and other provisions. Official Gazette 270 A’; 2014 p. 1889-1900.
19. Law 4052/2012. Article 11. Provisions for the implementation of Memorandum of Understanding. Official Gazette 41 A’; 2012 p. 1115-1182.
20. Ministerial Decree C5/63587. Claw back for pharmaceutical expenditure for years 2016, 2017, 2018. Official Gazette 1803 B’; 2015 p. 21279-21280.
21. Law 4208/2013. Article 3. Arrangments and other provisions of Ministry of Health. Official Gazette 252 A’; 2013 p. 4327-4334.
22. Klemp, M, Frønsdal, KB, Facey, K, HTAi Policy Forum. What principles should govern the use of managed entry agreements? Int J Technol Assess Health Care. 2011;27:77-83.
23. Law 4368/2016. Article 33. Healthcare coverage of unisured and vulnerable social groups. Official Gazette 21 A’; 2016 p. 537-612.
24. Gagnon, M-P, Candas, B, Desmartis, M, et al. Involving patient in the early stages of health technology assessment (HTA): A study protocol. BMC Health Serv Res. 2014;14:1-7.
25. European Commission. Transparent value framework (Platform on access to medicines in Europe - Working Group on Mechanism of coordinated access to orphan medicinal products) [Internet]. 2014. http://ec.europa.eu/DocsRoom/documents/7631?locale=en (accessed October 16, 2016).
26. Marsh, K, IJzerman, M, Thokala, P, et al. Multiple criteria decision analysis for health care decision making–Emerging good practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force. Value Health. 2016;19:125-137.
27. de Labry Lima, AO, Mochon, LG, Martínez, AC, Ruiz, EM, Balbino, JE. Mapping capacity to conduct health technology assessment in Central, Eastern and South-Eastern Europe. Croat Med J. 2016;57:66-70.
28. EUnetHTA Joint Action 2, Work Package 7, Subgroup 3, Heintz, E, Gerber-Grote, A, et al. Is There a European view on health economic evaluations? Results from a synopsis of methodological guidelines used in the EUnetHTA Partner Countries. Pharmacoeconomics. 2016;34:59-76.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 40
Total number of PDF views: 206 *
Loading metrics...

Abstract views

Total abstract views: 406 *
Loading metrics...

* Views captured on Cambridge Core between 31st July 2017 - 12th June 2018. This data will be updated every 24 hours.